This melatonin monitoring checklist helps caregivers track sleep, evening behavior, and possible melatonin effects in Alzheimer's disease. Melatonin is a brain hormone that helps signal nighttime sleep. Alzheimer's-related brain changes can disrupt the biological clock and confuse sleep-wake cycles. Evening agitation can carry into the night and make falling and staying asleep harder, according to the Alzheimer's Association in its sleep and sundowning guidance.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why sleep breaks down
- What should you track each day?
- What might melatonin do for evening restlessness?
- Which side effects and interactions need attention?
- How do you handle quality and follow-up?
Why sleep breaks down
Sundowning means late-day confusion, anxiety, pacing, or irritability. Fatigue, hunger, low light, and shadows can trigger it. The episode may not end at bedtime.
A disrupted clock shifts when the person feels alert or sleepy. Caregivers often see daytime napping followed by nighttime wakefulness. A written log makes that pattern visible.
What should you track each day?
Start with sleep, light, naps, and evening behavior. The Alzheimer's Association advises caregivers to monitor daily sleep logs, daytime light exposure, short early naps only, and a calm evening routine in its sleep and sundowning guidance.
Bring the log to medical visits. Patterns across two weeks matter more than one bad night.
- Bedtime, wake time, nighttime awakenings, and total sleep
- Morning and daytime bright-light time
- Nap length and nap time; keep naps short and early
- Evening routine, noise, light level, and screen use
- Sundowning signs, time they started, and likely triggers
What might melatonin do for evening restlessness?
Research suggests melatonin might reduce evening confusion and restlessness in people with Alzheimer's disease. It does not appear to improve cognition, according to Mayo Clinic licensed content in its melatonin overview. That distinction guides monitoring.
Watch for calmer evenings, fewer nighttime awakenings, and easier morning rising. Track memory and thinking separately and do not expect melatonin to change them. Ask the doctor what target behavior to watch. Set a review date rather than continuing indefinitely without direction.
Which side effects and interactions need attention?
Common melatonin effects include headache, dizziness, nausea, and drowsiness. Mayo advises treating it like a sleeping pill under doctor supervision. Avoid driving or machinery use within five hours.
Bleeding, blood pressure, blood sugar, sedation, and seizures deserve extra care. Melatonin can raise bleeding risk with anticoagulants or antiplatelets, worsen blood pressure control, alter blood sugar, add sedation with CNS depressants, and affect seizure drugs, according to Mayo Clinic licensed content in its melatonin interactions list. Call the prescribing clinician promptly about those changes. Include over-the-counter medicines, supplements, and alcohol use in the list.
- Unusual bruising, nosebleeds, or prolonged bleeding
- Morning grogginess, falls, dizziness, or confusion
- Higher or lower blood pressure or blood sugar readings
- Increased sleepiness with sleep, anxiety, pain, or allergy medicines
- More frequent or more severe seizures
How do you handle quality and follow-up?
U.S. melatonin is sold as a dietary supplement without FDA premarket approval for safety or efficacy. The maker is responsible for safety and truthful labeling. Keep the product name, lot number, dose, and purchase date with the sleep log.
Consistency matters because tested products varied widely from the label. In one analysis, many samples missed the labeled amount by more than 10%, and some contained unlisted serotonin. Do not switch brands, strengths, or forms without noting the change. Report suspected adverse events to the clinician and through FDA safety-reporting channels. Bring the bottle to the appointment.
